China Kangtai Cactus Bio-Tech Inc (fka CKGT)

[pegasus1]

Wasn't the payment for the patent to a related party? If they overpaid, that would most likely be why.

I'm torn on this company. Love the products and the growth story but really concerned they will or already are desperate for cash. I don't see that they have a history of managing large receivables on the scale they currently hold. And the collection issues that go hand in hand not to mention the estimates for doubtful accounts which can really impact earnings.

I hold another .ob stock with a history of issues collecting receivables. It's held the stock down. Now I might be holding another one.

Sure took a beating on this one today. I was hoping for a great Q like everyone else.